Anzeige
Erschienen in:
05.04.2023 | Original Article
Risk of upper gastrointestinal cancer and death in persons with negative screening results: results from the National Cancer Screening Program in South Korea
Erschienen in: Gastric Cancer | Ausgabe 4/2023
Einloggen, um Zugang zu erhaltenAbstract
Background
The Korea National Cancer Screening Program (KNCSP) offers upper endoscopy or upper gastrointestinal series (UGIS) biannually for people aged ≥ 40 years. This study aimed to assess the effect of negative screening results on the incidence of and mortality from upper gastrointestinal (GI) cancer.
Methods
A population-based retrospective cohort of 15,850,288 men and women was constructed using data from 3 national databases. The participants were followed until the end of 2017 for data on cancer incidence and in 2019 for data on the vital status. Cox proportional hazard model with time-varying exposure was used to assess the association.
Results
By the end of the follow-up period, 230,783 upper GI cancer cases and 99,348 upper GI cancer deaths were recorded. Negative gastric cancer screening was significantly associated with a lower risk of upper GI cancer in both UGIS (adjusted hazard ratio [aHR] = 0.81, 95% CI = 0.80–0.82) and upper endoscopy (aHR = 0.67, 95% CI = 0.67–0.68) groups. The HRs for upper GI mortality were 0.55 (95% CI = 0.54–0.56) and 0.21 (95% CI = 0.21–0.22) for the UGIS and upper endoscopy groups, respectively. The most significant reductions in the risk of upper GI cancer (UGIS: aHR = 0.76, 95% CI = 0.74–0.77; upper endoscopy: aHR = 0.60, 95% CI = 0.59–0.61) and death (UGIS: aHR = 0.54, 95% CI = 0.52–0.55; upper endoscopy: aHR = 0.19, 95% CI = 0.19–0.20) were observed among individual aged 60–69 years.
Conclusion
Negative screening cases, especially in upper endoscopy of the KNCSP, were associated with an overall reduction in the risk of and mortality from upper GI cancer.